Common questions about Rheomacrodex (FAQ)
Q: Is Rheomacrodex the same as regular Dextran?
A: Rheomacrodex is the brand name for Dextran 40, a specific type of low molecular weight Dextran. Products sometimes referred to as 'regular' Dextran typically have a higher molecular weight (e.g., Dextran 70). The molecular weight is important because it dictates how the solution works in the body as a volume expander and blood flow improver.
Q: Does Rheomacrodex thin the blood or just improve flow?
A: Official information indicates Rheomacrodex primarily works to improve blood flow by reducing blood viscosity (thickness) and preventing blood cells from clumping together. It also interferes with coagulation dynamics. This combination of effects helps improve overall circulation and modifies the flow characteristics of the blood.
Q: How quickly does Rheomacrodex start working after infusion?
A: According to official regulatory information, since the medicine is administered directly into the vein, the initial therapeutic effects of plasma volume expansion are considered to be rapid. This rapid action is crucial when the drug is used to treat or prevent shock.
Q: How long does the effect of Rheomacrodex last in the body?
A: Pharmacokinetic data shows that approximately 50% of the active ingredient is typically excreted through the kidneys within the first 3 hours, and about 75% within 24 hours. The remaining portion of the medication is metabolized and can stay in the body for several days.
Q: Is it normal to feel flush or dizzy during a Rheomacrodex infusion?
A: The official labeling for Rheomacrodex lists symptoms related to vascular issues, including Hypotension (low blood pressure), which can cause dizziness. Hypersensitivity reactions may also occur, which could potentially include flushing. Any unusual or concerning sensations experienced during the infusion should be communicated to the healthcare provider.
Q: Can Rheomacrodex be used for deep vein thrombosis (DVT)?
A: The approved indication is for the prophylaxis (prevention) of venous thromboembolism, which includes DVT, in patients who have undergone high-risk surgical procedures. It is not approved for use as a primary treatment for an existing, fully formed DVT.
Q: Why does Rheomacrodex sometimes cause a drop in blood pressure?
A: Hypotension (low blood pressure) is listed in the regulatory documents as a potential adverse reaction. This reaction may occur as a severe symptom of an anaphylactic (allergic) reaction, or it may be related to changes in fluid dynamics following rapid volume expansion or hemodilution.
Q: Why is my urine output monitored closely when I'm on Rheomacrodex?
A: Close monitoring of urine output is essential because this medication is contraindicated in patients with severe kidney disease. Monitoring helps medical staff assess for potential signs of renal (kidney) impairment and manage fluid balance.
Q: Does Rheomacrodex show up on a drug test?
A: Official labeling states that the presence of Dextran may interfere with certain laboratory assays, such as those for blood typing, bilirubin, and total protein. However, there is no official information stating that the drug interferes with common drug screening tests.
Q: Does alcohol interact negatively with Rheomacrodex treatment?
A: Official regulatory interaction checkers list no specific known negative interactions between alcohol and this medication. Always confirm with the prescribing healthcare provider about any potential risks associated with alcohol consumption during treatment.
Q: Can Rheomacrodex cause itching or hives after the infusion is complete?
A: Hypersensitivity reactions, including urticaria (hives) or pruritus (itching), are officially documented adverse reactions. The most severe reactions are reported to occur early in the infusion period. Less severe symptoms are also possible, although official reports focus on reactions occurring early in the infusion period.
Q: Why do doctors use Rheomacrodex instead of normal saline sometimes?
A: Rheomacrodex is a colloid solution classified as a Plasma Volume Expander, whereas normal saline is a crystalloid. Rheomacrodex is engineered to remain in the bloodstream longer to maintain volume, and it offers the added benefit of an anti-aggregation effect to improve blood flow, a function saline does not provide.
Q: What is the connection between Rheomacrodex and tissue perfusion?
A: The drug's mechanism of action involves decreasing blood viscosity and preventing the clumping of blood cells. This action increases the rate of blood flow in small vessels (microcirculation), which in turn enhances the perfusion—or delivery of blood—to the body’s tissues, helping to maintain oxygenation.
Q: Does Rheomacrodex come in a pill form?
A: No. According to the official product labeling, Rheomacrodex is supplied solely as a sterile solution for intravenous infusion. It is only administered directly into a vein under medical supervision.
Q: Can Rheomacrodex be given outside of a hospital setting?
A: The drug is administered by intravenous infusion and requires a specific, multi-step administration protocol, including the required use of another solution (Dextran 1) beforehand. This specialized procedure suggests it must be administered in a specialized medical setting.
Q: Has Rheomacrodex been studied for use in treating burns?
A: Yes. The official indications for the medication include its use as an adjunctive therapy for treating or preventing shock due to conditions that include burns, in addition to hemorrhage, trauma, or surgical complications.
Q: What happens if Rheomacrodex is given too quickly?
A: The official warnings state that rapid infusion can increase the risk of serious adverse reactions related to fluid overload. these include the potential for developing pulmonary edema (fluid in the lungs) or exacerbating existing congestive heart failure.
Q: Is Rheomacrodex always clear, or can its color vary?
A: Official handling instructions state that the solution must be clear and free of particulate matter prior to administration. Medical staff are explicitly warned not to use the solution if it has become cloudy or if crystallization has occurred.
Q: How is Rheomacrodex stored before use?
A: It must be stored at a controlled room temperature (20 C to 25 C) and must be protected from freezing. The solution should be checked for clarity before use.
Q: Does Rheomacrodex affect blood sugar levels?
A: The product is a solution of Dextran 40 dissolved in an aqueous solution of Dextrose (glucose). Scientific literature cited in regulatory reviews suggests that the administration of Dextran has been associated with increases in blood glucose levels.
Q: What are the alternatives to Rheomacrodex for volume expansion?
A: The medication is not a replacement for whole blood or blood components when they are needed. Other alternatives for fluid and volume expansion may include crystalloid solutions (such as normal saline) or other colloid solutions, depending on the specific clinical needs of the patient.
Q: Is Rheomacrodex still considered a standard treatment today?
A: Official safety information notes that due to the availability of alternatives, careful patient selection and monitoring are crucial in contemporary clinical practice. This suggests that while still used, it may not be the sole or primary standard treatment for every scenario.
